| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHINTE.1987.00370110040005 |
| P698 | PubMed publication ID | 3675091 |
| P2093 | author name string | Hällgren R | |
| Vessby B | |||
| Lithell H | |||
| Svenson KL | |||
| Selinus I | |||
| P433 | issue | 11 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 1912-1916 | |
| P577 | publication date | 1987-11-01 | |
| P1433 | published in | JAMA Internal Medicine | Q177428 |
| P1476 | title | Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity | |
| P478 | volume | 147 |
| Q57944660 | A Modified Form of Low-Density Lipoprotein with Increased Electronegative Charge is Present in Rheumatoid Arthritis Synovial Fluid |
| Q44126592 | Active-dimeric form of lipoprotein lipase increases in the adipose tissue of patients with rheumatoid arthritis treated with prednisolone |
| Q74456133 | Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo-high-density lipoproteinemia and reduced lipoprotein-associated platelet-activating factor acetylhydrolase activity |
| Q34897630 | Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study |
| Q36596894 | Atherogenic lipid profiles and its management in patients with rheumatoid arthritis |
| Q37174146 | Autoimmune-mediated glucose intolerance in a mouse model of systemic lupus erythematosus |
| Q34730722 | Cardiovascular risk profile of antirheumatic agents in patients with osteoarthritis and rheumatoid arthritis |
| Q80089332 | Clinical features, serum interleukin-6, and interferon-gamma levels of 34 turkish patients with hepatoportal sclerosis |
| Q71691123 | Dynamic changes of plasma lipids and lipoproteins in patients after transient ischemic attack or minor stroke |
| Q35029916 | Dyslipidaemia in rheumatological autoimmune diseases |
| Q35547301 | Dyslipidemia and rheumatoid arthritis |
| Q69601426 | Dyslipoproteinemia in juvenile rheumatoid arthritis |
| Q38745362 | Effects of synthetic and biological disease modifying antirheumatic drugs on lipid and lipoprotein parameters in patients with rheumatoid arthritis |
| Q35553196 | Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity |
| Q33561449 | Evening primrose oil in rheumatoid arthritis: changes in serum lipids and fatty acids |
| Q53653844 | Glucocorticoid use is associated with increase in HDL and no change in other lipids in rheumatoid arthritis patients. |
| Q35794642 | Homocysteine and lipid profile in children with Juvenile Idiopathic Arthritis. |
| Q71814896 | Hyperlipidaemia in renal transplantation—risk factor for long‐term graft outcome |
| Q46027578 | Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis. |
| Q37129611 | Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study. |
| Q33563669 | Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis |
| Q35549009 | Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease |
| Q45004490 | Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation |
| Q51002495 | Plasma lipids and lipoproteins in juvenile chronic arthritis. |
| Q68013395 | Serum cholesterol levels during and after Kawasaki disease |
| Q74080640 | The contribution of synovial fluid lipoproteins to the chronic synovitis of rheumatoid arthritis |
| Q44432184 | Transient reductions in serum cholesterol after renal transplantation |
Search more.